Healius | HLS - Ebitda

Harga Saham

0.54

Perubahan Harian

0.01 0.94%

Bulanan

0%

Tahunan

-61.79%

Q2 Perkiraan

0.52

Keuangan

AUD

AUD 3.07B

AUD 60.1M

Biaya Penjualan

AUD 218.7M

AUD 1.04B

Kewajiban Lancar

AUD 804.2M

AUD 1.4B

Dividen - Hasil

7.19

AUD 23.7M

AUD 74.9M

8K

Eps Laba Per Saham

AUD -0.04

Modal Dan Cadangan

AUD 1.03B

Laba Kotor Pada Penjualan

AUD 554.4M

Beban Bunga Utang

AUD 32.8M

AUD 1.22B

Kapitalisasi Pasar

AUD 388.46M

Batas Pemasukan

AUD -12.8M

Biaya Operasional

AUD 684.9M

Laba Operasional

AUD -22.6M

Modal Saham Biasa

AUD 2.6B

Pe Harga Untuk Laba

57.43

Laba Sebelum Pajak

AUD -19.2M

Pendapatan Penjualan

AUD 688.1M

Beban Penjualan Dan Administrasi

AUD 393.4M

AUD 31.9M

Kreditur Perdagangan

AUD 133.9M

Debitur Perdagangan

AUD 144.6M

	Ebitda	Perubahan		Tanggal
Alcidion	AUD 4.19M		365K	2025-12
Ansell	USD 185.8M		7M	2025-12
Cochlear	AUD 306.4M		13.5M	2025-12
CSL	USD 3.13B		1.17B	2025-12
Fisher Paykel Healthcare	NZD 364M		78.5M	2025-06
Integral Diagnostics	AUD 46.27M		3.52M	2024-06
Mayne Pharma	AUD 20.9M		5.2M	2025-06
Nanosonics	AUD 12.49M		1.13M	2025-12
Polynovo	AUD 3.89M		100K	2025-12
Ramsay Health Care	AUD 1.12B		10.6M	2025-12
ResMed	USD 547.48M		27.46M	2025-12
Sigma Healthcare	AUD 19.96M		5.15M	2024-07
Sonic Healthcare	AUD 839.07M		51.09M	2024-12